Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study ; volume:7 ; number:1 ; day:18 ; month:7 ; year:2014 ; pages:1-11 ; date:12.2014
BMC Research Notes / Biomed Central; 7, Heft 1 (18.7.2014), 1-11, 12.2014
- Creator
-
Clayton, Anita H.
Baker, Ross A.
Sheehan, John J.
Cain, Zachary J.
Forbes, Robert A.
Marler, Sabrina Vogel
Marcus, Ronald
Berman, Robert M.
Thase, Michael E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-0500-7-459
- URN
-
urn:nbn:de:101:1-2019102906531485332943
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Clayton, Anita H.
- Baker, Ross A.
- Sheehan, John J.
- Cain, Zachary J.
- Forbes, Robert A.
- Marler, Sabrina Vogel
- Marcus, Ronald
- Berman, Robert M.
- Thase, Michael E.
- SpringerLink (Online service)
Other Objects (12)
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
Prenatal exposure to serotonin reuptake inhibitors: a case report
Selective serotonin reuptake inhibitors induce cell death via the unfolded protein response
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Selective serotonin reuptake inhibitors: a new modality for the treatment of lymphoma/leukaemia?
Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem study
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
Prenatal exposure to serotonin reuptake inhibitors: a case report
Selective serotonin reuptake inhibitors induce cell death via the unfolded protein response
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Selective serotonin reuptake inhibitors: a new modality for the treatment of lymphoma/leukaemia?
Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem study
Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis
Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
Prenatal exposure to serotonin reuptake inhibitors: a case report
Selective serotonin reuptake inhibitors induce cell death via the unfolded protein response
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Selective serotonin reuptake inhibitors: a new modality for the treatment of lymphoma/leukaemia?
Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model